Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ensartinib Hydrochloride Capsules

Approval Number

国药准字H20200010

Company贝达药业股份有限公司

Registration Date

November 17, 2020

Drug Information

Generic Name

盐酸恩沙替尼胶囊

Trade Name

贝美纳

Brand Name

贝美纳

Dosage Form

胶囊剂

Strength

100mg(按C26H27Cl2FN6O3计)

Drug Type

化学药品

Registration Date

November 17, 2020

Company Information

Applicant Company

Company Name贝达药业股份有限公司

Company Address

浙江省杭州市临平区经济技术开发区兴中路355号

Manufacturing Company

Company Name贝达药业股份有限公司

Company Address

浙江省杭州市临平区经济技术开发区兴中路355号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸恩沙替尼胶囊 - NMPA 批准文号 | MedPath